about
Targeting SOX2 as a Therapeutic Strategy in GlioblastomaMethylation silencing of ULK2, an autophagy gene, is essential for astrocyte transformation and tumor growthVandetanib plus sirolimus in adults with recurrent glioblastoma: results of a phase I and dose expansion cohort studyChloroquine enhances gefitinib cytotoxicity in gefitinib-resistant nonsmall cell lung cancer cells.mTOR Inhibition: From Aging to Autism and Beyond.mTOR in Brain Physiology and Pathologies.Clinical relevance of autophagic therapy in cancer: Investigating the current trends, challenges, and future prospects.The Autophagoproteasome a Novel Cell Clearing Organelle in Baseline and Stimulated Conditions.MIR137 Regulates Starvation-Induced Autophagy by Targeting ATG7.mTOR inhibition and levels of the DNA repair protein MGMT in T98G glioblastoma cells.Rapamycin promotes differentiation increasing βIII-tubulin, NeuN, and NeuroD while suppressing nestin expression in glioblastoma cellsNew Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection.mTOR-Dependent Cell Proliferation in the Brain.A fully coupled space-time multiscale modeling framework for predicting tumor growth.Age-Dependent Cellular and Behavioral Deficits Induced by Molecularly Targeted Drugs Are Reversible.Autophagy-deficient breast cancer shows early tumor recurrence and escape from dormancy.Coordinated autophagy modulation overcomes glioblastoma chemoresistance through disruption of mitochondrial bioenergetics.
P2860
Q28079501-CC6C87B3-FF14-4417-A01E-43DD486D7738Q34070445-3EECD6EF-2A71-43FB-ACF6-D4F9184D4DD4Q35071684-E8EFD295-CA56-46EC-90BA-D94170D03BDEQ35217204-A782915F-A219-4927-973A-7C3B13F59756Q37385781-52E9197C-9624-41D2-B20A-8218E6AC8E80Q38565769-95674150-4F0F-491E-84B4-D1C56144C1C5Q38689955-481BB23B-A117-4C19-933E-49C0662CB5A1Q38753705-FBDC2807-4B6D-4ECA-B041-FEF79C28262CQ38908916-CC8B13AF-C038-4E13-923B-A7BA975F9F79Q38987085-C3D5F742-733E-48D6-89F1-103789126041Q42244908-86295D7E-678A-47DD-8514-AB489BACA19EQ47222125-44F488B9-8D02-47EB-BEC3-0A69234E84AFQ47231432-EA6BAE4E-E5F8-46CE-9D4A-373EAEEA9A0BQ47329365-0A46806C-F069-4DD3-928A-D78E26790DCDQ53429907-8AE2683C-7A5D-4A30-8DF9-469B466D3E46Q55313431-8948164B-2A61-4D29-BF12-58997663946BQ55553613-6C0D5F03-8996-418C-A856-0A6754BEB281
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Rapamycin inhibits the growth of glioblastoma.
@en
Rapamycin inhibits the growth of glioblastoma.
@nl
type
label
Rapamycin inhibits the growth of glioblastoma.
@en
Rapamycin inhibits the growth of glioblastoma.
@nl
prefLabel
Rapamycin inhibits the growth of glioblastoma.
@en
Rapamycin inhibits the growth of glioblastoma.
@nl
P2093
P50
P1433
P1476
Rapamycin inhibits the growth of glioblastoma
@en
P2093
Alessandro Frati
Giampaolo Cantore
Maria Antonietta Oliva
P356
10.1016/J.BRAINRES.2012.11.044
P407
P50
P577
2012-12-19T00:00:00Z